Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders | 06/27 12:29 | newsfilecorp.com |
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT | 06/25 07:27 | newsfilecorp.com |
Cardiol Therapeutics releases Phase II data showing CardiolRx reduces pericarditis pain and inflammation | 06/13 12:10 | proactiveinvestors.com |
Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis | 06/13 07:58 | newsfilecorp.com |
5 Small Drug Stocks to Buy From a Recovering Industry | 05/24 10:02 | zacks.com |
CRDL Stock Earnings: Cardiol Therapeutics Meets EPS for Q1 2024 | 05/14 22:53 | investorplace.com |
Cardiol Therapeutics surpasses 85% enrollment in ARCHER trial for acute myocarditis | 05/14 09:38 | proactiveinvestors.com |
Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024 | 05/14 07:27 | newsfilecorp.com |
Cardiol Therapeutics surpasses enrolment goals, prepares for topline results | 04/02 09:46 | proactiveinvestors.co.uk |
Cardiol Therapeutics surpasses enrollment goals, prepares for topline results | 04/02 09:36 | proactiveinvestors.com |